ethyl loflazepate has been researched along with Kidney Failure, Chronic in 1 studies
ethyl loflazepate: structure given in first source
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In contrast, elimination half-life and total plasma clearance of the sum of loflazepate + descarboxyloflazepate seemed to be independent of the degree of renal impairment." | 1.28 | Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man. ( Ba, BB; Berger, Y; Cano, JP; Durand, A; Iliadis, A; Necciari, J, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ba, BB | 1 |
| Iliadis, A | 1 |
| Durand, A | 1 |
| Berger, Y | 1 |
| Necciari, J | 1 |
| Cano, JP | 1 |
1 other study available for ethyl loflazepate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effect of renal failure on the pharmacokinetics of ethyl loflazepate (Victan) in man.
Topics: Administration, Oral; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Female; | 1989 |